INHIBITION OF STREPTOLYSIN-S BY THE SERUM OF PATIENTS WITH RHEUMATIC FEVER AND ACUTE STREPTOCOCCAL PHARYNGITIS
INHIBITION OF STREPTOLYSIN-S BY THE SERUM OF PATIENTS WITH RHEUMATIC FEVER AND ACUTE STREPTOCOCCAL PHARYNGITIS
复制标题
DOI:
10.1172/jci102352
复制
发表时间:
1950-01-01
影响因子:
15.9
通讯作者:
BERNHEIMER, AW
中科院分区:
文献类型:
--
作者:
STOLLERMAN, GH;BERNHEIMER, AW
The sera of normal subjects and patients with rheumatic fever, streptococcal pharyngitis and miscellaneous diseases were titrated for their capacity to inhibit streptolysin S, a hemolysin produced by Group A streptococci. 80% of patients with acute rheumatic fever showed a fall in the serum level of streptolysin S inhibitor below normal values during severe rheumatic activity and a return to normal levels during convalescence. A low streptolysin S inhibitor titer was also encountered in some cases of unrelated diseases and the fall, therefore, does not appear to be specific for rheumatic fever. Patients with acute pharyngitis due to Group A streptococci showed no change in titer. In patients with rheumatic fever there was no elevation in streptolysin S inhibitor in contrast to the marked rise in antistreptolysin O and antistreptokinase titers measured on the same sera. 23 strains of Group A streptococci isolated from the throats of patients with acute pharyngitis and from those with rheumatic fever were shown to be capable of producing streptolysin S in vitro. These findings indicate that streptolysin S is not antigenic in man and that the capacity of serum to inhibit streptolysin S is due to a normal component of serum rather than to a specific antibody. The nature of the streptolysin S inhibitor and the significance of its decrease in rheumatic fever are discussed.